Visiongain Publishes Biologics Market Report 2024-2034

The biologics market is estimated at US$447 billion in 2023 and is projected to grow at a CAGR of 8.5% during the forecast period 2024-2034.

Visiongain Publishes mRNA Vaccines Market Report 2023-2033

The global mRNA Vaccines market is estimated at US$11,773.3 million in 2023 and is projected to grow at a CAGR of 10.5% during the forecast period 2023-2033.

Visiongain Publishes Stem Cell Technologies and Applications Market Report 2023-2033

The global Stem Cell Technologies and Applications market is estimated at US$10,059.6 million in 2023 and is projected to grow at a CAGR of 8.7% during the forecast period 2023-2033.

Visiongain Publishes Neurology Clinical Trials Market Report 2023-2033

The global Neurology Clinical Trials market is valued at US$9,609.2 million in 2023 and is projected to grow at a CAGR of 5.4% during the forecast period 2023-2033.

Visiongain Publishes Pharma Contract Sales Market Report 2023-2033

The global Pharma Contract Sales market is valued at US$7,678.6 million in 2023 and is projected to grow at a CAGR of 8.2% during the forecast period 2023-2033.

Visiongain Publishes Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2024-2034

The global Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs market is valued at US$24.2 billion in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period 2024-2034.

Visiongain Publishes Influenza Vaccines Market Report 2023-2033

The global Influenza Vaccines market is valued at US$6,648.0 million in 2023 and is projected to grow at a CAGR of 10.5% during the forecast period 2023-2033.

Visiongain Publishes Antisense Oligonucleotide (ASO) Therapeutics Market Report 2023-2033

The global Antisense Oligonucleotide (ASO) Therapeutics market is valued at US$6,099.3 million in 2023 and is projected to grow at a CAGR of 14.5% during the forecast period 2023-2033.

Visiongain Publishes Macular Degeneration (AMD) and Other Retinal Diseases Drugs Market Report 2023-2033

The global Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is valued at US$15.6 billion in 2023 and is projected to grow at a CAGR of 7.4% during the forecast period 2023-2033.

Visiongain Publishes Orphan Drugs Market Report 2023-2033

The global Orphan Drugs market is valued at US$187.6 billion in 2022 and is projected to grow at a CAGR of 11.1% during the forecast period 2023-2033.

Visiongain Publishes 3D Cell Culture and 3D Bioprinting Market Report 2023-2033

The global 3D Cell Culture and 3D Bioprinting market is valued at US$2,277.2 million in 2023 and is projected to grow at a CAGR of 17.8% during the forecast period 2023-2033.

Visiongain Publishes Bioreactors Market Report 2023-2033

The global Bioreactors market was estimated to be valued at US$9,977.0 million in 2023 and is expected to register a CAGR of 12.2% from 2023 to 2033.

Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033

The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033

The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.

Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033

The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.

Visiongain Publishes Contract Research Organisations (CROs) Market Report 2023-2033

The global Contract Research Organisations (CROs) market was valued at US$68.9 billion in 2023 and is projected to grow at a CAGR of 10.6% during the forecast period 2023-2033.

Visiongain Publishes Stem Cell Therapy Contract Manufacturing Market Report 2023-2033

The global Stem Cell Therapy Contract Manufacturing market was valued at US$2,495.1 million in 2022 and is projected to grow at a CAGR of 12.4% during the forecast period 2023-2033.

Visiongain Publishes Immuno-Oncology Clinical Trials Market Report 2023-2033

Immuno-Oncology Clinical Trials market is valued at US$6,849.8 million in 2023 and is projected to grow at a CAGR of 11.3% during the forecast period 2023-2033.

Visiongain Publishes In Silico Clinical Trials Market Report 2023-2033

The global In Silico Clinical Trials market is valued at US$3,078.0 million in 2023 and is projected to grow at a CAGR of 8% during the forecast period 2023-2033.

Visiongain Publishes Bionic Devices Market Report 2023-2033

The global Bionic Devices market was valued at US$19.5 billion in 2022 and is projected to grow at a CAGR of 9.5% during the forecast period 2023-2033.

Clients & Partners